Pamela Stephenson

Corporate Officer/Principal presso DISC MEDICINE, INC.

Patrimonio netto: 1 M $ in data 31/05/2024

56 anni

Health Technology

Consumer Services

Posizioni attive di Pamela Stephenson

Società	Posizione	Inizio	Fine
DISC MEDICINE, INC.	Corporate Officer/Principal	26/02/2024	-

Società	Posizione	Inizio	Fine
ZYNERBA PHARMACEUTICALS, INC.	Direttore/Membro del Consiglio	19/02/2019	10/10/2023
ZYNERBA PHARMACEUTICALS, INC.	Independent Dir/Board Member	19/02/2019	10/10/2023
VERTEX PHARMACEUTICALS INCORPORATED	Corporate Officer/Principal	01/07/2008	01/03/2019
ALBIREO PHARMA, INC.	Corporate Officer/Principal	25/03/2019	-

Brown University	Undergraduate Degree
Boston University School of Public Health	Graduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	3
Director/Board Member	1
Independent Dir/Board Member	1

Settori

Health Technology	5
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	3
ZYNERBA PHARMACEUTICALS, INC.	Health Technology
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology
DISC MEDICINE, INC.	Health Technology

Aziende private	1
Albireo Pharma, Inc. Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.	Health Technology

Aziende private

Health Technology